-+ 0.00%
-+ 0.00%
-+ 0.00%

AMYLYX PHARMACEUTICALS TO ANNOUNCE TOPLINE RESULTS FROM ITS PHASE 3 LUCIDITY CLINICAL TRIAL OF AVEXITIDE IN POST-BARIATRIC HYPOGLYCEMIA ON AUGUST 18, 2026

Reuters·08/17/2026 20:01:00

Please log in to view news